IAM Patent 1000 has once again recognised Carpmaels & Ransford in its rankings. In 2019, the firm remains highly recommended for patent prosecution work, with 13 partners recommended individually by the publication. This year the firm is delighted to announce that in addition to its top tier patent prosecution recognition, the expertise of our litigation team has also been recognised with the firm moving up to silver in the 2019 rankings.
“the best law firm I have worked with in Europe, and possibly worldwide”.
According to IAM Patent 1000: Carpmaels & Ransford is “a great firm that is especially strong on the life sciences prosecution scene” but with serious credentials in other technical areas as well. The firm has been diversifying its practice recently, and its push to provide litigation capabilities to match its renowned non-contentious offering has proven extremely successful. As one satisfied client expounds: “Carpmaels & Ransford is tremendous, very good at prosecution, but where it really stands out is in complex opposition and SPC work.” The firm’s litigation offering is led by David Wilson, an “extremely diligent pharmaceuticals and telecoms litigator who is excellent to work with internationally” and has acted in cases all the way to the Supreme Court. Ian Kirby is “an old school IP litigator; persuasive, effective, measured in tone and guided by knowledge, reasoning and experience”. Camilla Balleny’s life sciences advocacy is no less coveted; described as being an “outstanding solicitor”, she is “wonderful to work with, responsive, intelligent and organised”. On the prosecution side of the practice, Carpmaels & Ransford has an embarrassment of riches. Recent addition Harvey Adams is an “excellent lateral hire”, he is renowned for his ability to flawlessly defend drug patents in proceedings before the EPO. His acquisition adds to an already stacked life sciences team. Hugh Goodfellow captains the squad; a crucial link within the firm, he combines his booming prosecution practice with regular EPO visits. Medicinal chemistry ace James Warner is used to facing large and formidable teams on the other side of an EPO opposition; he is “extremely good at digging into the technical details of a case” and never falls short with his arguments. Edward Oates focuses on pharmaceutical matters and possesses a forensic knowledge of SPC law that has attracted a slew of new clients. As one illustrates: “Edward is technically very astute and understands complex science in the biotech area that would be beyond many other patent attorneys – he sets the bar extremely high for his colleagues.” In the words of one leading continental practitioner, Cameron Marshall “is a very strategic analyst”. Biologics and pharmaceuticals wizard Daniel Wise is yet another seasoned EPO strategy specialist, while Susan Kirsch’s know-how spans many chemical fields: “she is excellent at understanding inventions technically, as well as being clear, convincing and easy to follow.” Carpmaels & Ransford’s engineering and technology group is also going great guns, with three practitioners in particular standing out. Richard Jackson is the firm’s managing partner, he is a “first-class” patent attorney of 30 years’ vintage whose advice is always “pragmatic and professional”. Physical sciences guru Chris Tunstall is a “very talented, proactive counsel who gives timely and sage advice regarding European patent practice”. The versatile John Brunner has an impressive reputation in cutting-edge fields, including fintech, drug delivery and artificial intelligence. Overall, it is not difficult to understand why one client deems Carpmaels & Ransford to be “the best law firm I have worked with in Europe, and possibly worldwide”.